Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Clinical trial NCT04688788 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04688788
Sponsor: Rigshospitalet, Denmark
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis Secondary Progressive Multiple Sclerosis Primary Progressive Multiple Sclerosis

Start date: 2021-04-28
Primary completion: 2026-06-10
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.